Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
There is increasing evidence showing the role of fatty acids and their derived lipid intermediates in the regulation of skeletal muscle mass synthesis and function. However, the role of omega-3 fatty acids remains unclear. Therefore, we conducted a meta-analysis to evaluate the potential effects of omega-3 fatty acids on sarcopenia-related performances among the elderly. Eligible literature and reports of randomized controlled trials were comprehensively searched from the PubMed, Cochrane Library, ClinicalTrials.gov, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases until July 2018. A total of 10 articles were available for the meta-analysis. There were minor benefits for muscle mass gain (0.33 kg; 95% CI: 0.05, 0.62) and timed up and go performance (−0.30 s; 95% CI: −0.43, −0.17). Subgroup analyses regarding muscle mass and walk speed indicated that omega-3 fatty acid supplements at more than 2 g/day may contribute to muscle mass gain (0.67 kg; 95% CI: 0.16, 1.18) and improve walking speed, especially for those receiving more than 6 months of intervention (1.78 m/sec; 95% CI: 1.38, 2.17). Our findings provide some insight into the effects of omega-3 fatty acids on muscle mass, especially for those taking supplements at more than 2 g/day. We also observed that a long period of omega-3 fatty acids supplementation may improve walking speed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mice, acute administration raised circulating GLP-1 and insulin, improving glucose tolerance, an effect abrogated by a GLP-1 receptor antagonist (exendin-9), indicating an incretin-mediated hypoglycemic action [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mice, acute administration raised circulating GLP-1 and insulin, improving glucose tolerance, an effect abrogated by a GLP-1 receptor antagonist (exendin-9), indicating an incretin-mediated hypoglycemic action [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Experimental — accuracy not yet measuredIn the citing paper
“Taken together, evidence indicates that bitter melon could enhance the weight loss and glycemic benefits of GLP-1RAs by increasing endogenous GLP-1 and by improving metabolic profiles [193,194,198,199].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
In the citing paper
“In in vitro studies using the enteroendocrine cell line (STC-1), bitter melon extracts dosedependently increase GLP-1 release, an effect partially blocked by a bitter taste receptor antagonist (probenecid) and by a phospholipase Cβ2 inhibitor (U-73122), suggesting a taste receptor-mediated mechanism [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
In the citing paper
“In in vitro studies using the enteroendocrine cell line (STC-1), bitter melon extracts dosedependently increase GLP-1 release, an effect partially blocked by a bitter taste receptor antagonist (probenecid) and by a phospholipase Cβ2 inhibitor (U-73122), suggesting a taste receptor-mediated mechanism [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · cited 1×
“The methodological quality of included studies was evaluated according to the Cochrane Collaboration risk-of-bias tool [28].”
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“This systematic review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [27].”
MethodSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“The recently updated consensus EWGSOP guideline for the case-finding and diagnosis of sarcopenia (EWGSOP2) focused on low muscle strength (and not low muscle mass) as a principal feature of sarcopenia [45].”
BackgroundSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 2×
“The original definition of sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) was the “presence of both low muscle mass + low muscle function (strength or performance)” [3].”
BackgroundMethodGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Meaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“This change is clinically relevant in the context of aging [49].”
BackgroundDisability in Older Adults: Evidence Regarding Significance, Etiology, and Risk
Fried, L. P., & Guralnik, J. M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00986.x · Cited by 866
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665 · cited 4×
“An association between n-3 PUFAs intake and musculoskeletal health has also been reported in RCTs [18,19], which showed that supplementation with n-3 PUFAs enhanced the rate of muscle protein synthesis in the elderly; in a strength-training trial [20], fish-oil supplementation resulted in significantly improved muscle…”
ResultInfluential
Cited by
Items 101–155 of 155
n-3 Polyunsaturated fatty acids improve sarcopenia by mitochondrial quality control
Bian, D., Su, S., Cheng, X., Shi, Y., Wang, X., & Yan, Y. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107221 · Cited by 2
Foscolou, A., Pratti, T., Detopoulou, P., Argyri, K., Nikolaou, G., Kouskouti, A., Malikourti, A., Petrogianni, M., Shurdha, E., Psaroudaki, E., et al. (2025) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70169 · Cited by 2
Wei, X., Guo, S., Ren, Z., Zhong, P., Su, B., Talifu, Z., & Zheng, X. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01254-x · Cited by 2
“Omega-3(ω−3) fatty acids are widely well-studied classes of fatty acids known for their protective effects on muscle mass; supplementation with more than 2 g/day of ω−3 fatty acids was associated with an increase in muscle mass of 0.33 kg in older adults [58].”
InfluentialDilesh, N. R., Khatri, D., Shrivastava, R., & Kushwaha, S. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70194 · Cited by 2
Wu, H., Zhang, Q., Liu, L., Meng, G., Gu, Y., Yao, Z., Zhang, S., Wang, Y., Zhang, T., Wang, X., et al. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.04.002 · Cited by 2
Self-citationFatty Acid Content of Farmed Rainbow Trout: How Much Should We Consume for Enough EPA and DHA?
Bayir, H., & Arslan, M. (2022) · Aquaculture Studies · doi:10.4194/aquast986 · Cited by 2
“Beneficial effects on muscle mass and the walking speed of people with sarcopenia muscle disease who take more than 2 g of omega-3 LC-PUFAs supplements per day have been reported (Huang et al., 2020).”
BackgroundWang, B., He, S., Nong, C., Zhang, J., Li, W., Wei, Y., Liu, P., Wang, F., Liu, K., Ma, F., et al. (2025) · PubMed Central · doi:10.6133/apjcn.202504_34(2).0012 · Cited by 2
Hussein, K., Kistler-Fischbacher, M., Mattle, M., Molino, C. D. G. R. C., Tsai, L., Kressig, R. W., Orav, E. J., Sliva, J. A. P. D., Vellas, B. J., Rizzoli, R., et al. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100528 · Cited by 1
SPORCU PERFORMANSINI ARTIRAN GÜNCEL BESİN TAKVİYELERİ
Bor, H. (2025) · Ankara Üniversitesi Beden Eğitimi ve Spor Yüksekokulu SPORMETRE Beden Eğitimi ve Spor Bilimleri Dergisi · doi:10.33689/spormetre.1535816 · Cited by 1
“…al., 2020) - Kas işleyişini iyileştirme, inflamasyonu azaltma ve egzersiz kaynaklı kas hasarı iyileşme hızını artırma (Mesta and Medithi, 2023) Kas kütlesi kazanımı ve yürüme hızını artış (Huang et al., 2020) Endotel fonksiyonu iyileştirme, vazodilatasyonu teşvik etme, antioksidan ve…”
InfluentialWawrzyńców, J. T., Cyrkler, W., Robak, J., Telega, S., Bollin, P., Szymczak, U., Lachór, W. W., Solarz, M. B., Piekarska, J., & Solarz, J. M. (2025) · Quality in Sport · doi:10.12775/qs.2025.40.59775 · Cited by 1
Long-Chain Omega-3 Polyunsaturated Fatty Acids and Sarcopenia
Heileson, J. L., & Sergi, T. E. (2025) · Nutrition Today · doi:10.1097/nt.0000000000000759 · Cited by 1
Tan, J., Chen, X., Peng, Z., Bai, H., Shi, L., Sun, Y., & Chen, J. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2564239 · Cited by 1
“Previous studies have demonstrated that omega-3 fatty acids can increase muscle mass and enhance muscle function, thereby reducing the risk of sarcopenia and slowing the progression of this condition [34,35].”
Skeletal muscle disuse atrophy: protection by omega-3 polyunsaturated fatty acids
Obrosov, O., Coppey, L. J., Davidson, E. P., Ebert, S. M., Adams, C. M., & Yorek, M. A. (2025) · NFS Journal · doi:10.1016/j.nfs.2025.100253 · Cited by 1
“Several meta-analyses revealed that supplementing diets of older adults with omega-3 poly unsaturated fatty acids improved overall body mass, strength, functionality, and walking speed especially if study participants took more than 2 g/day [5,6,3].”
Hubungan Asupan Asam Lemak Omega-3 dengan Massa Otot Skeletal dan Level VO2 Max
Ratu, L. A. (2024) · Nutrizione Nutrition Research And Development Journal · doi:10.15294/nutrizione.v4i2.16060 · Cited by 1
Dimopoulou, M., Madesis, P. B., Dimopoulou, A. M., & Gortzi, O. (2026) · Foods · doi:10.3390/foods15061079 · Cited by 1
“A meta-analysis of older adults found that when supplementation exceeded 2 g/day of omega-3 PUFA, and a duration of ≥ 6 months, there was some benefit, e.g., muscle mass gain ~0.67 kg (95% CI 0.16–1.18 kg) and improved walking speed [92].”
InfluentialDalmay, D., Pinto, J. M., Gámez-Fernández, M. M., Robbins, D., Wells, J. E. T., Gough, L. A., Witard, O. C., & Deb, S. K. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuag102 · Cited by 1
Cortesi, A., Tzanetakou, I. P., Giannakou, K., Tzanetakou, A. B. , & Hadjimbei, E. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1872170 · Cited by 1
“These mechanisms may explain why grip strength and functional performance gains are more consistently reported than increases in total muscle mass across omega-3 supplementation trials in the elderly (Huang et al., 2020; Therdyothin et al., 2023; Tomczyk, 2024).”
Le, P.-Q., Kim, J. H., Park, K., & Lee, B. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127496 · Cited by 1
The Role of Omega 3 Fatty Acids on Muscle Mass: A Literature Review
Wardhana, P. A. K. (2024) · Journal La Medihealtico · doi:10.37899/journallamedihealtico.v5i2.1169 · Cited by 1
“However, there is still much debate about the effects of omega 3 on muscle mass in its potential to increase muscle protein synthesis which can lead to increased muscle mass (Lalia et al., 2017; Cornish et al., 2022; Huang et al., 2020).”
BackgroundPatrones dietéticos en el aumento de masa muscular en adultos mayores: Una revisión sistemática
Carrera, C. C., Álvarez, H. R. P., Castillo, M. M., & Javier, F. D. P. G. (2024) · RESPYN Revista de Salud Pública y Nutrición · doi:10.29105/respyn23.3-800 · Cited by 1
Lecová, M., Babjáková, D., Sopková, D., Andrejčáková, Z., Hertelyová, Z., Petrilla, V., Polláková, M., & Vlčková, R. (2024) · Life · doi:10.3390/life14020240
“It has been established that SFAs are lipotoxic while USFAs are nontoxic and have favorable cellular functions [19,60,62,63].”
BackgroundFilho, M. L. M., Almada, L. B., Souza, P. L., de Castro, J. B. P., Vieira, J. G., de Sousa, A. V., Vianna, J. M., Aidar, F. J., & Venturini, G. R. D. O. (2024) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv16n7-011
Einflussnehmende Faktoren der medizinischen Trainingstherapie
Wolfram, S., & Bauer, R. (2024) · Springer eBooks · doi:10.1007/978-3-662-69586-9_7
Association of Dietary Inflammatory Index with Omega-3 Index in Female Athlete
FUJIBAYASHI, M., Suganuma, A., Domichi, M., Hayashi, I., YAMAKATA, R., FUJIKAWA, H., Kumano, A., Kijima, K., Tomokane, S., Ogura, Y., et al. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.55 · Cited by 1
“A meta-analysis by Huang et al. revealed positive effects of n-3 PUFAs on muscle mass, particularly in individuals consuming doses exceeding 2 g/d ( 48 ).”
韦, 继. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152481
Influencing Factors of Medical Exercise Therapy
Wolfram, S., & Bauer, R. (2025) · Springer eBooks · doi:10.1007/978-3-662-70774-6_7
Dalmao‐Fernández, A., Katare, P. B., Bakke, H. G., Hamarsland, H., Ellefsen, S., Singh, S. K., Nyman, T. A., Kase, E. T., Rustan, A. C., & Thoresen, G. H. (2025) · In vitro models · doi:10.1007/s44164-025-00087-6
“Muscle mass was significantly increased, however, muscle strength seemed not to be increased by omega-3 PUFA [32].”
Novel two variable-QSPR analysis for authentication and typification of vegetable oils
Duchowicz, P. R., Mandelbaum, M. G., Vitale, A. A., & Pomilio, A. B. (2025) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2025.109126
Role of Omega-3 Supplementation in Clinical and Athletic Populations
Niharika, T., Ala, N. J., & Mekam, M. (2025) · International Journal of Science and Research (IJSR) · doi:10.21275/sr251126225631
Bootsma, N. (2022) · Stirling Online Research Repository (University of Stirling)
Ikääntyneen toimintakykyä edistävä ravitsemus : Narratiivinen kirjallisuuskatsaus
Sjöblom, A. (2025) · Theseus (Ammattikorkeakoulujen)
Zhan, P., Yan, S.-B., Liu, Y., Li, X.-X., Geng, J., Yuan, H.-T., & Shang, G.-K. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-11049-6 · Cited by 1
“The application of specialized pro-resolving mediators (SPMs) has demonstrated beneficial effects on sarcopenia [ 88, 89 ].”
Menéndez, I. M. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Radfar, B., Bagheri, R., Ghobadi, H., Hematabadi, A., Askari, B., Rashidlamir, A., & Dutheil, F. (2026) · Nutrients · doi:10.3390/nu18040611
Zhang, Z., Jiang, Y., Su, S., Wang, L., & Bian, D. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113455
“7 Furthermore, mechanistic studies remain largely confined to the phenotypic level, with limited exploration using multi-omics approaches integrating lipidomics, metabolomics and gut microbiota analyses.”
Tamargo, J. A., Carvajal, E., Simić, K., Przkora, R., Anton, S. D., & Cruz‐Almeida, Y. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101517
Ogawa, S., Wakabayashi, H., Suzuki, N., Jinno, M., Inoue, T., Maeda, K., Yamamoto, K., Rakugi, H., Akishita, M., & Arai, H. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70296
Hupalowski, N. N., Sanches, C. P., Andrade, V. F. C., Boguszewski, C. L., & Borba, V. Z. C. (2026) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2026-0048
Bigolin, A. V., Iaroseski, J., Carteri, R. B., Rodrigues, G. S., de Andrade, R., Carli, L. A. D., Razzera, E. L., Vian, I., da Silva, R. D. A., Kalil, A. N., et al. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70321
“Other RCTs, such as Logan et al. [26], and meta-analyses, like the one by Huang et al. [27], corroborate these effects, although these studies were conducted in older populations.”
Xu, S., Wen, S., Zong, X., Jianwei, Z., Du, Q., Li, Y., Wang, K., Cao, P. H., Ding, C., Zhang, Y., et al. (2026) · Aging Cell · doi:10.1111/acel.70617
Zhong, Z., Chen, Y., Xiang, Q. X., Liu, H., Zhao, M., Pekovic‐Vaughan, V., Sund, R., Sankaranarayanan, R., Cuthbertson, D. J., & Isanejad, M. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047621
dos Santos, M. V. N., Pires, A. C. D. S., Duarte, A. L. H., & de Souza, M. L. R. (2025) · REVISTA CIENTÍFICA DA FAMINAS · doi:10.54397/rcfaminas.v20i2.998 · Cited by 1
Supplementation with Fish Oil Rich in Omega-3 Fatty Acids Delays Age-Associated Muscle ChangesPreprint
Horlem, T., Matthes, B. B., Rodriguez, D. F. S., Maciel, M., Zazula, M. F., Fernandes, L. C., & Naliwaiko, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.02.742308
“Studies report that n-3 improves muscle protein synthesis, increases the cross-sectional area of muscle fibers, promotes contractile quality and greater strength, and enhances global functionality in older adults [26–28].”
Turco, A., Lippi, L., Uberti, F., Alessandro de, S. I. R. E., & Invernizzi, M. (2026) · Dietetics · doi:10.3390/dietetics5040055
“When combined with physical exercise and rehabilitation protocols, these bioenergetic improvements translate into a potent anabolic-sensitizing effect in geriatric patients [67,68].”
Ni, J., Shen, L., & Gao, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1932144
ANTARCTIC KRILL OIL AND SKELETAL-MUSCLE FUNCTION: HUMAN EVIDENCE FOR STRENGTH AND RECOVERY
Ziraoui, A., Sari, M., & Saito, S. (2026) · Journal of Healthcare Science and Management · doi:10.61796/jhsm.v1i4.38
“A meta-analysis in older adults found that effects differed across muscle mass, strength and performance measures [4], while work on exercise-induced muscle damage has emphasized the timing of recovery assessments and the diversity of training protocols [5].”
Pegreffi, F., Chiaramonte, R., Leo, T. D., Gallo, C., Ruscica, M., Mirisola, P., Nerozzi, E., Zeppa, S. D., Bartolacci, A., Russo, A., et al. (2024) · Giornale Italiano di Ortopedia e Traumatologia
Zhang, X., Fan, S., Zan, J., Chen, M., & Chen, X. (2026) · Nutrients · doi:10.3390/nu18203368
“Previous evidence suggests that omega-3 fatty acids may influence muscle health in older adults by modulating inflammatory responses and the sensitivity of muscle protein synthesis [10], while microbiota-targeted interventions have also attracted increasing attention in relation to sarcopenia [59].”
Dietary supplements to support healthy aging
Evans, C., Gilbert, G., Schwarz, A. V., Pereira, F., Byers, P. H., Emerson, K., Vasenina, K., Barelli, V., Naddafha, S., & António, J. (2026) · Longevity · doi:10.1080/30653495.2026.2743481
Lai, R., Jin, L., Chen, S., Li, R., Wang, M., & Zhang, L. (2026) · Japan Journal of Nursing Science · doi:10.1111/jjns.70084
Ahn, Y., Westra, J., Tintle, N., Harris, W. S., & Park, Y. (2026) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2026.101019
Shao, Y., Yin, S., Wu, T., 邹灿, Yang, J., Feng, P., Zhou, Y., & Sun, G. (2026) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr49111
Metadata
- Authors
- Huang, Y.-H., Chiu, W.-C., Hsu, Y.-P., Lo, Y.-L., & Wang, Y.-H.
- Affiliations
- Taipei City Hospital (TW)
- Taipei Medical University (TW)
- Wan Fang Hospital (TW)
- National Yang Ming University (TW)
- Taipei Medical University-Shuang Ho Hospital (TW)
- Corresponding author
- Wang, Yuan-Hung
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-12-04
- Volume
- 12
- Issue
- 12
- Pages
- 3739
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7761957
- OpenAlex
- W3108657423
- Cited by
- 142
- References
- 50
- Citations by year
- 2026: 21 · 2025: 40 · 2024: 29 · 2023: 23 · 2022: 16 · 2021: 13
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- omega-3 fatty acids, dietary supplementation, sarcopenia, muscle mass, muscle strength, muscle performance, older adults, Timed Up and Go test, walking speed
- MeSH terms
- Physical Functional Performance, Aged, Diet, Docosahexaenoic Acids, Female, Gait, Humans, Male, Middle Aged, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Muscle, Skeletal, Dietary Supplements, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.